{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:39:12Z","timestamp":1787611152442,"version":"build-2736575974"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.01663","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T08:54:37Z","timestamp":1580374477000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Identifying the Naphthalene-Based Compound 3,5-Dihydroxy 2-Napthoic Acid as a Novel Lead Compound for Designing Lactate Dehydrogenase-Specific Antibabesial Drug"],"prefix":"10.3389","volume":"10","author":[{"given":"Long","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangnan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"52300","DOI":"10.1074\/jbc.M409175200","article-title":"The expression of lactate dehydrogenase is important for the cell cycle of Toxoplasma gondii","volume":"279","author":"Al-Anouti","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S247","DOI":"10.1017\/s0031182004005190","article-title":"Babesiosis of cattle","author":"Bock","year":"2004","journal-title":"Parasitology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.molbiopara.2004.03.009","article-title":"Identification of Babesia bovis L-lactate dehydrogenase as a potential chemotherapeutical target against bovine babesiosis","volume":"136","author":"Bork","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ejmech.2017.12.051","article-title":"Antimalarial naphthoquinones. Synthesis via click chemistry, in vitro activity, docking to PfDHODH and SAR of lapachol-based compounds","volume":"145","author":"Brandao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"31429","DOI":"10.1074\/jbc.M402433200","article-title":"Identification and activity of a series of azole-based compounds with lactate dehydrogenase-directed anti-malarial activity","volume":"279","author":"Cameron","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B6","article-title":"Clindamycin and quinine treatment for Babesia microti infections","volume":"32","year":"1983","journal-title":"MMWR Morb. Mortal Wkly Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1021\/cc060110n","article-title":"Generation of oxamic acid libraries: antimalarials and inhibitors of Plasmodium falciparum lactate dehydrogenase","volume":"9","author":"Choi","year":"2007","journal-title":"J. Comb. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.molbiopara.2005.03.015","article-title":"Mapping the binding site for gossypol-like inhibitors of Plasmodium falciparum lactate dehydrogenase","volume":"142","author":"Conners","year":"2005","journal-title":"Mol. Biochem. Parasitol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"9102","DOI":"10.1093\/nar\/gks700","article-title":"Sequencing of the smallest Apicomplexan genome from the human pathogen Babesia microti","volume":"40","author":"Cornillot","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0166-6851(01)00360-7","article-title":"The kinetic properties and sensitivities to inhibitors of lactate dehydrogenases (LDH1 and LDH2) from Toxoplasma gondii: comparisons with pLDH from Plasmodium falciparum","volume":"118","author":"Dando","year":"2001","journal-title":"Mol. Biochem. Parasitol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1021\/jm980334n","article-title":"Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum","volume":"41","author":"Deck","year":"1998","journal-title":"J. Med. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/nsb1196-912","article-title":"The structure of lactate dehydrogenase from Plasmodium falciparum reveals a new target for anti-malarial design","volume":"3","author":"Dunn","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s0166-6851(97)00140-0","article-title":"Substrate and cofactor specificity and selective inhibition of lactate dehydrogenase from the malarial parasite P. falciparum","volume":"90","author":"Gomez","year":"1997","journal-title":"Mol. Biochem. Parasitol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.3201\/eid1812.111392","article-title":"Reservoir competence of wildlife host species for Babesia microti","volume":"18","author":"Hersh","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7263","DOI":"10.1007\/s00216-018-1337-7","article-title":"Binding properties of broad-specific monoclonal antibodies against three organophosphorus pesticides by a direct surface plasmon resonance immunosensor","volume":"410","author":"Jiao","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1021\/bi035108g","article-title":"Structure of Toxoplasma gondii LDH1: active-site differences from human lactate dehydrogenases and the structural basis for efficient APAD+ use","volume":"43","author":"Kavanagh","year":"2004","journal-title":"Biochemistry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1056\/NEJM200011163432004","article-title":"Atovaquone and azithromycin for the treatment of babesiosis","volume":"343","author":"Krause","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of lactate dehydrogenase a induces oxidative stress and inhibits tumor progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.4155\/fmc-2017-0046","article-title":"Recent advances in gossypol derivatives and analogs: a chemistry and biology view","volume":"9","author":"Lu","year":"2017","journal-title":"Future Med. Chem."},{"key":"B20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1126\/science.6750791","article-title":"Inhibitory action of gossypol on enzymes and growth of Trypanosoma cruzi","volume":"218","author":"Montamat","year":"1982","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2174\/1573406415666181219100307","article-title":"Synthesis, plasmodium falciparum inhibitory activity, cytotoxicity and solubility of n2,n4 -disubstituted quinazoline-2,4-diamines","volume":"15","author":"Pobsuk","year":"2019","journal-title":"Med. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/0031-6989(86)90023-8","article-title":"Antiviral activities of gossypol and its derivatives against herpes simplex virus type II","volume":"18","author":"Radloff","year":"1986","journal-title":"Pharmacol. Res. Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"9184","DOI":"10.1021\/acs.jmedchem.7b00941","article-title":"Discovery and optimization of potent, cell-active pyrazole-based inhibitors of lactate dehydrogenase (LDH)","volume":"60","author":"Rai","year":"2017","journal-title":"J. Med. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/pl00008549","article-title":"Antimalarial activity of new gossypol derivatives","volume":"86","author":"Razakantoanina","year":"2000","journal-title":"Parasitol. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.surg.2016.09.009","article-title":"FX11 inhibits aerobic glycolysis and growth of neuroblastoma cells","volume":"161","author":"Rellinger","year":"2017","journal-title":"Surgery"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1021\/jm00159a043","article-title":"Biologically active derivatives of gossypol: synthesis and antimalarial activities of peri-acylated gossylic nitriles","volume":"29","author":"Royer","year":"1986","journal-title":"J. Med. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/1043-6618(91)90045-y","article-title":"Inhibition of human immunodeficiency virus type I replication by derivatives of gossypol","volume":"24","author":"Royer","year":"1991","journal-title":"Pharmacol. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1021\/jm00013a018","article-title":"Synthesis and anti-HIV activity of 1,1\u2019-dideoxygossypol and related compounds","volume":"38","author":"Royer","year":"1995","journal-title":"J. Med. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1080\/07391102.2018.1471417","article-title":"Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH)","volume":"37","author":"Saxena","year":"2018","journal-title":"J. Biomol. Struct. Dyn"},{"key":"B30","doi-asserted-by":"publisher","first-page":"35284","DOI":"10.1038\/srep35284","article-title":"Genome-wide diversity and gene expression profiling of Babesia microti isolates identify polymorphic genes that mediate host-pathogen interactions","volume":"6","author":"Silva","year":"2016","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1128\/JCM.39.12.4316-4322.2001","article-title":"Human babesiosis in Japan: epizootiologic survey of rodent reservoir and isolation of new type of Babesia microti-like parasite","volume":"39","author":"Tsuji","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.5858\/arpa.2017-0250-RS","article-title":"Transfusion-Transmitted Babesiosis","volume":"143","author":"Villatoro","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.exppara.2005.06.007","article-title":"Plasmodium falciparum: stage specific effects of a selective inhibitor of lactate dehydrogenase","volume":"109","author":"Vivas","year":"2005","journal-title":"Exp. Parasitol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4137\/DTI.S16504","article-title":"Molecular and kinetic characterization of babesia microti gray strain lactate dehydrogenase as a potential drug target","volume":"8","author":"Vudriko","year":"2014","journal-title":"Drug Target Insights"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1128\/JCM.00504-17","article-title":"Babesia microti: from mice to ticks to an increasing number of highly susceptible humans","volume":"55","author":"Westblade","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0010-7824(88)90029-7","article-title":"Studies of the mechanism of action of gossypol as a male antifertility agent","volume":"37","author":"White","year":"1988","journal-title":"Contraception"},{"key":"B37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1086\/649859","article-title":"Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection","volume":"50","author":"Wormser","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s0006-2952(01)00636-0","article-title":"Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C4","volume":"62","author":"Yu","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"13669","DOI":"10.1096\/fj.201901259R","article-title":"Crystal structures of Babesia microti lactate dehydrogenase BmLDH reveal a critical role for Arg99 in catalysis","volume":"33","author":"Yu","year":"2019","journal-title":"FASEB J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1292\/jvms.66.785","article-title":"Epizootiologic survey for Babesia microti among small wild mammals in northeastern Eurasia and a geographic diversity in the beta-tubulin gene sequences","volume":"66","author":"Zamoto","year":"2004","journal-title":"J. Vet. Med. Sci."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005250","article-title":"Cryptosporidium lactate dehydrogenase is associated with the parasitophorous vacuole membrane and is a potential target for developing therapeutics","volume":"11","author":"Zhang","year":"2015","journal-title":"PLoS Pathog."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01663\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T08:54:38Z","timestamp":1580374478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01663\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":41,"alternative-id":["10.3389\/fphar.2019.01663"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.01663","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,30]]},"article-number":"1663"}}